| pubmed-article:1615557 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1615557 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:1615557 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:1615557 | lifeskim:mentions | umls-concept:C0017393 | lld:lifeskim |
| pubmed-article:1615557 | lifeskim:mentions | umls-concept:C0220898 | lld:lifeskim |
| pubmed-article:1615557 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1615557 | pubmed:dateCreated | 1992-7-30 | lld:pubmed |
| pubmed-article:1615557 | pubmed:abstractText | The investigation concerning the dependence of cancer incidence on genetic HLA-markers and character of dermatoglyphs was carried out. The use of the pattern recognition method for multifactorial estimation of the above markers as well as the elimination of the main non-genetic oncogenic risk factors allowed obtaining the proof of the existence of the genetic predisposition to lung cancer. It was estimated that the character of dermatoglyphic prints is the most adequate marker for the investigated predisposition, and the reliable prediction of the genetic risk of the lung cancer development can be given as based on the joint evaluation of both markers. | lld:pubmed |
| pubmed-article:1615557 | pubmed:language | rus | lld:pubmed |
| pubmed-article:1615557 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1615557 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1615557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1615557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1615557 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1615557 | pubmed:issn | 0564-3783 | lld:pubmed |
| pubmed-article:1615557 | pubmed:author | pubmed-author:Katsnel'sonB... | lld:pubmed |
| pubmed-article:1615557 | pubmed:author | pubmed-author:PolzinE AEA | lld:pubmed |
| pubmed-article:1615557 | pubmed:author | pubmed-author:KhodyrevV NVN | lld:pubmed |
| pubmed-article:1615557 | pubmed:author | pubmed-author:LezhninV LVL | lld:pubmed |
| pubmed-article:1615557 | pubmed:author | pubmed-author:IakushevaM... | lld:pubmed |
| pubmed-article:1615557 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1615557 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:1615557 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1615557 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1615557 | pubmed:pagination | 36-41 | lld:pubmed |
| pubmed-article:1615557 | pubmed:dateRevised | 2008-2-15 | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:meshHeading | pubmed-meshheading:1615557-... | lld:pubmed |
| pubmed-article:1615557 | pubmed:articleTitle | [Genetic markers of individual predisposition to lung cancer]. | lld:pubmed |
| pubmed-article:1615557 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1615557 | pubmed:publicationType | English Abstract | lld:pubmed |
